NASDAQ:ACHL

Achilles Therapeutics

Stock

USD

Last Close

0.95

25/09 14:38

Market Cap

34.51M

Beta: 0.94

Volume Today

123.01K

Avg: 193.80K

PE Ratio

−0.53

PFCF: −15.51

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-13.99M -	-33.20M 137.31%	-61.10M 84.04%	-71.18M 16.49%	-69.94M 1.74%
depreciation and amortization	302K -	772K 155.63%	3.29M 325.91%	3.69M 12.23%	4.73M 28.22%
deferred income tax	14K -		159K -
stock based compensation	719K -	2.99M 316.13%	6.32M 111.13%	7.02M 11.16%
change in working capital	-1.18M -	3.00M 355.01%	-7.93M 364.01%	-5.96M 24.90%	10.45M 275.44%
accounts receivables
inventory
accounts payables	548K -	5.26M 859.49%	-2.57M 148.92%	1.91M 174.14%
other working capital	-1.73M -	-2.25M 30.59%	-5.36M 137.76%	-7.86M 46.73%	10.45M 232.89%
other non cash items	-9K -	1.18M 13,200%	-18K 101.53%	6.88M 38,350%	6.12M 11.15%
net cash provided by operating activities	-14.14M -	-25.25M 78.56%	-59.28M 134.77%	-59.53M 0.42%	-48.64M 18.31%
investments in property plant and equipment	-942K -	-11.85M 1,157.64%	-7.63M 35.56%	-7.51M 1.60%	-1.10M 85.30%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-942K -	-11.85M 1,157.64%	-7.63M 35.56%	-7.51M 1.60%	-1.10M 85.30%
debt repayment
common stock issued	94.01M -	114.59M 21.89%	160.75M 40.29%	1K 100.00%	9.03K 803.49%
common stock repurchased
dividends paid
other financing activites	-387.56K -	-884.50K 128.23%
net cash used provided by financing activities	93.62M -	113.70M 21.45%	160.75M 41.38%	1K 100.00%	9.03K 803.49%
effect of forex changes on cash	8.37M -	3.65M 56.41%	-5.33M 246.14%	-25.93M 386.22%	7.93M 130.59%
net change in cash	86.91M -	80.25M 7.66%	88.50M 10.28%	-92.98M 205.06%	-41.80M 55.05%
cash at beginning of period	10.68M -	97.59M 813.54%	177.85M 82.23%	266.35M 49.76%	173.34M 34.92%
cash at end of period	97.59M -	177.85M 82.23%	266.35M 49.76%	173.37M 34.91%	131.54M 24.13%
operating cash flow	-14.14M -	-25.25M 78.56%	-59.28M 134.77%	-59.53M 0.42%	-48.64M 18.31%
capital expenditure	-942K -	-11.85M 1,157.64%	-7.63M 35.56%	-7.51M 1.60%	-1.10M 85.30%
free cash flow	-15.08M -	-37.10M 145.95%	-66.92M 80.38%	-67.05M 0.19%	-49.74M 25.81%

All numbers in USD (except ratios and percentages)